Godavari Drugs

quarterly
yearly
ParticularsJun '22Sep '22Dec '22Mar '23Jun '23
Revenue42.5540.5539.1637.3735.42
Expenses40.6138.4537.4034.9533.64
EBITDA1.942.101.762.421.78
EBIT1.481.631.251.921.31
Profit Before Tax1.271.170.951.541.12
Net Profit0.920.860.671.330.81
Financial Ratios
Operating Profit Margin4.56%5.18%4.49%6.48%5.00%
Net Profit Margin2.16%2.12%1.71%3.56%2.29%
Earning Per Share (Diluted)1.221.150.891.511.08
Dividends Per ShareNANANANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.3.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ